VIVES Partners’ Post

We are pleased to support Generare in its seed funding round! 👏   🦠 Generare is taking bacteria found in soil and breaking down their genetic code to uncover untapped bioactive molecules, called Natural Products (NPs), at unprecedented speed.   🌱 NPs were once the gold-standard for drug-discovery; penicillin being a prime example. They have led to 500+ anticancer, antibiotics and immunosuppressive drugs, yet their discovery in recent years has plateaued even though molecules from microbes are 100x more likely to gain approval than those from plants or chemistry.   🔓 Generare is reopening this critical avenue of discovery and doing so at scale. Using its patent-pending techniques it has already identified 100+ previously unknown molecules.   🚀 We are proud to support such an innovative company utilizing natural products, which we truly believe is the future of the agricultural, biotech and pharma sectors.   👏 Congratulations to Guillaume Vandenesch, Dr Vincent Libis and the Generare team, we can’t wait to see what you do next! Teampact.ventures Galion.exe SynBioVen Saras Capital Better Angle   #seedfunding #biotech #agritech #naturalproducts #funding #syntheticbio #innovation

We are thrilled to welcome Eligo Bioscience into our portfolio! 👏   🧬 Eligo, founded on the basis of pioneering science from Rockefeller university, MIT and Pasteur institute, is developing first-in-class modalities that deliver #CRISPR and therapeutic genetic circuits directly to the #microbiome, enabling precise editing of both its genetic composition and function.   📈 Eligo is progressing toward a key milestone: advancing its lead program into clinical trials for moderate to severe #acne, a skin condition with high unmet medical need for safe and efficacious therapies.   🤝 The company also welcomes genetic pioneer Dr Bobby Gaspar, CEO of Orchard Therapeutics as Chairman of its board of directors.   🚀 We are proud to support such an innovative and growing company with expert leadership behind it. Congratulations to Dr Gaspar on his new role and we are excited to see how Xavier Duportet and Dr Gaspar develop Eligo further! https://lnkd.in/e5reYyJ7 #platform #genetics #acne #biotech #geneediting #appointment #funding #partnership

We are excited to announce that Yannick Vancoppenolle from VIVES Partners will be attending the World Agri-Tech Innovation Summit in the UK! 🇬🇧   🗓 Join us on September 30-October 1 at the InterContinental in the O2 London for a day of innovation and networking.   🌎 The event aims to unite over 1,000 business leaders and key stakeholders dedicated to driving advancements in climate-resilient, sustainable agriculture across the supply chain from farm to fork.   🤝 Don't miss the chance to meet Yannick to discuss how VIVES Partners can help provide both capital and expertise to drive startup success and shape the future of agritech together!   Find out more about the summit 👇 https://lnkd.in/gQ6UfGz   #AgriTech #AgriFood #Biotech #Innovation #Startups #Entrepreneurship

We are happy to announce that Sandra Schoors has been promoted to partner! 📚 You’ve met Sandra before – she brings 7 years of experience in Life Science investments, with an interest and focus on oncology and genetic disease therapeutics. Her deep knowledge of the life sciences is backed by her remarkable academic achievements, including having her thesis on the role of metabolism in angiogenesis published in Nature and Cell. 🚀 At VIVES, Sandra’s skills in company creation and her knowledge of life sciences will prove invaluable in driving our mission forward: bringing innovative research and startups to market and creating a positive impact in the world. 🎉 Congratulations, Sandra! We’re excited to see the incredible things we will achieve together. #Promotion #Appointment #LifeSciences #Innovation #Investment #Leadership #VentureCapital #WomenInBusiness